Source link : https://www.newshealth.biz/health-news/extended-dosing-intervals-possible-with-aflibercept-in-diabetic-macular-edema/
Positive 3-year results from the phase III PHOTON study were presented at the recent American Academy of Ophthalmology (AAO) meeting, demonstrating that patients with diabetic macular edema (DME) achieved sustained vision improvements with extended dosing intervals and no new safety signals with aflibercept 8 mg (Eylea HD). MedPage Today brought together three expert leaders in […]
Author : News Health
Publish date : 2024-11-18 20:14:59
Copyright for syndicated content belongs to the linked Source.